Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/6e3042d1-238b-40a1-83af-b061f6f9ed58/
ESLA
Estrella Immunopharma Inc.Snapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
54.0%ile
FCF Yield
-0.174
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
46.00000000
/100 — 1=cheapest
VC2 (Trending Value)
46.00000000
/100
VC3 (Buyback)
46.00000000
/100
Negative FCF yield (-17.4%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
53.0%ile
ROE
2.514
ROA
-3.623
D/E
-1.69
Current
0.24
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.592
lower=better
Accruals
-1.431
lower=better
5yr Consist
No
ROE of 251% is exceptional. Conservative balance sheet with D/E of -1.69. F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
54.0%ile
6M Return
-42.7%
12M Return
7.0%
12-1 Mom
18.3%
Risk-Adj
0.14
Vol 252d
129.5%
Vol 60d
326.6%
↑ Expanding
Max DD 12M
-66.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (327%) is expanding vs long-term (129%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.61
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
43.9%
Sector Quality %ile
42.7%
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (327%) significantly exceeds 252-day (129%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
5.5% avg (2 factors)
Quality
B
60.0% avg (5 factors)
Momentum
D
31.8% avg (4 factors)
Risk
F
0.0% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.610 | —0 | — | |
| Value %ile | 0.540 | —0 | — | |
| Quality %ile | 0.530 | —0 | — | |
| Momentum %ile | 0.540 | —0 | — | |
| F-Score | 1.000 | —1 | — | |
| Confidence | 0.576 | —0 | — | |
| Volatility | 1.295 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
FCF Yield
-17.4%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
251.4%
Return on Assets
-362.3%
Debt / Equity
-1.69
Current Ratio
0.24
Accruals Ratio
(NI-OCF)/Assets — lower=better
-1.431
MomentumPrice trend strength over different horizons
6M Return
-42.7%
12M Return
7.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
18.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.14
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.592
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
46
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
46
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
46
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity